These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38693750)

  • 41. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
    Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
    Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does positron emission tomography scanning improve survival in patients undergoing potentially curative lung resections for non-small-cell lung cancer?
    Fontaine E; McShane J; Carr M; Shackcloth M; Mediratta N; Page R; Poullis M
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):642-6. PubMed ID: 21342771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study).
    Kadota T; Tsukada Y; Ito M; Katayama H; Mizusawa J; Nakamura N; Ito Y; Bando H; Ando M; Onaya H; Fukuda H; Kanemitsu Y
    Jpn J Clin Oncol; 2020 Aug; 50(8):953-957. PubMed ID: 32409830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgery for young patients with lung cancer.
    Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
    Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    Tsutani Y; Handa Y; Shimada Y; Ito H; Ikeda N; Nakayama H; Yoshimura K; Okada M
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1244-1252.e1. PubMed ID: 33213872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 49. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
    J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The progression of non-small cell lung cancer from diagnosis to surgery.
    McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival?
    Srikantharajah D; Ghuman A; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):893-8. PubMed ID: 22859511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early and late recurrence after intentional limited resection for cT1aN0M0, non-small cell lung cancer: from a multi-institutional, retrospective analysis in Japan.
    Matsumura Y; Yano M; Yoshida J; Koike T; Kameyama K; Shimamoto A; Nishio W; Yoshimoto K; Utsumi T; Shiina T; Watanabe A; Yamato Y; Watanabe T; Takahashi Y; Sonobe M; Kuroda H; Oda M; Inoue M; Tanahashi M; Adachi H; Saito M; Hayashi M; Otsuka H; Mizobuchi T; Moriya Y; Takahashi M; Nishikawa S; Suzuki H;
    Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):444-9. PubMed ID: 27226401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting recurrence of non-small cell lung cancer based on mean computed tomography value.
    Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Takata M
    J Cardiothorac Surg; 2021 May; 16(1):128. PubMed ID: 33980268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics and timing of recurrence during postoperative surveillance after curative resection for lung adenocarcinoma.
    Koike T; Goto T; Kitahara A; Sato S; Saitoh M; Hashimoto T; Namura O; Takahashi M; Toyabe SI; Tsuchida M
    Surg Today; 2017 Dec; 47(12):1469-1475. PubMed ID: 28474203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neoadjuvant Radiochemotherapy Followed by Curative Resection in Patients with Advanced Non-Small Cell Lung Cancer in Stage IIIA/IIIB: Prognostic Factors and Results].
    Schreiner W; Dudek W; Lettmaier S; Gavrychenkova S; Rieker R; Fietkau R; Sirbu H
    Zentralbl Chir; 2016 Jun; 141(3):323-9. PubMed ID: 27035568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type.
    Choi YS; Shim YM; Kim K; Kim J
    J Korean Med Sci; 2004 Oct; 19(5):674-6. PubMed ID: 15483342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.